Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening in liver disease.

Paolo Del Poggio, Marzio Mazzoleni

    World Journal of Gastroenterology
    |September 19, 2006
    PubMed
    Summary
    This summary is machine-generated.

    Screening for viral hepatitis C and genetic hemochromatosis is challenging due to target population identification. Improving opportunistic screening and general practitioner detection skills is key for effective disease management.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Clinical course and prognostic risk factors of SARS-CoV-2 vaccine-related hepatitis: differentiating severe acute respiratory syndrome coronavirus 2 vaccine-associated liver injury from autoimmune hepatitis.

    European journal of gastroenterology & hepatology·2026
    Same author

    Metabolic dysfunction outperforms ultrasonographic steatosis to stratify hepatocellular carcinoma risk in patients with advanced hepatitis C cured with direct-acting antivirals.

    Liver international : official journal of the International Association for the Study of the Liver·2023
    Same author

    Histological and serological features of acute liver injury after SARS-CoV-2 vaccination.

    JHEP reports : innovation in hepatology·2022
    Same author

    Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real-Life Cohort Study.

    Hepatology communications·2021
    Same author

    Surveillance for hepatocellular carcinoma at the community level: Easier said than done.

    World journal of gastroenterology·2021
    Same author

    Immune and cellular damage biomarkers to predict COVID-19 mortality in hospitalized patients.

    Current research in immunology·2021
    Same journal

    Lessons from extended induction and practical evidence for improving tofacitinib therapy in ulcerative colitis.

    World journal of gastroenterology·2026
    Same journal

    Small animal <i>ex vivo</i> machine perfusion of the liver: A comprehensive literature review.

    World journal of gastroenterology·2026
    Same journal

    Comparable remission and health care use in real-world inflammatory bowel disease patients initiating originator biologics <i>vs</i> biosimilars.

    World journal of gastroenterology·2026
    Same journal

    Diagnosis and management of metabolic dysfunction-associated steatohepatitis in patients with chronic hepatitis B infection.

    World journal of gastroenterology·2026
    Same journal

    Simultaneous treatment of concomitant achalasia coexisting with epiphrenic diverticulum: The practice of submucosal tunneling technique.

    World journal of gastroenterology·2026
    Same journal

    Lianhe Xiaozhi ointment ameliorates metabolic dysfunction-associated steatotic liver disease <i>via</i> peroxisome proliferator-activated receptor alpha pathway activation.

    World journal of gastroenterology·2026
    See all related articles

    Area of Science:

    • Hepatology
    • Public Health
    • Screening Programs

    Background:

    • Screening criteria include disease prevalence, target population reachability, test availability, and effective therapy.
    • Viral hepatitis C and genetic hemochromatosis are common liver diseases with varying suitability for screening.

    Discussion:

    • Hepatitis C screening faces challenges in defining target populations, with opportunistic screening of high-risk groups being common but often underperforming.
    • General practitioner training can improve opportunistic screening for Hepatitis C, while mass screening is costly.
    • Genetic hemochromatosis screening lacks sufficient evidence for general population screening, but targeted screening of high-prevalence groups is possible.

    Key Insights:

    • Opportunistic screening for Hepatitis C is the primary strategy, but its effectiveness is limited by low performance rates among general practitioners.

    Related Experiment Videos

  • Targeted screening for genetic hemochromatosis in specific populations (e.g., Northern European ancestry) may be considered.
  • Improving general practitioner diagnostic skills and opportunistic screening strategies is crucial for early detection of these liver diseases.

    • Outlook:

    • Further research into cost-effective screening strategies for viral hepatitis C is needed.
    • Enhanced training programs for healthcare professionals can improve early detection rates.
    • Continued evaluation of screening effectiveness and population health outcomes is essential.